Educational Development Corporation
EDUC News Today: Stay Updated with the Latest Educational Development Corporation News in Real Time
Find EDUC news now at Meyka AI. Stay informed with the latest Educational Development Corporation stocks updates, including price news, market analysis, and expert insights.
2103.HK Stock Trades at HK$0.50 on HKSE, 369M Volume
2103.HK (Sinic Holdings) trades at HK$0.50 with 369M volume on HKSE. Real estate developer with B grade rating.
ZEC Stock Today April 27: Zcash Surges 30% vs Bitcoin’s Stagnation
Zcash (ZEC) surges 30% in one month amid privacy coin momentum and developer restructure. Compare ZEC vs Bitcoin performance today.
9161.T Stock Bounces at ¥6,480 on April 28 Pre-Market
9161.T (Integrated Design & Engineering) trades at ¥6,480 in pre-market. Stock shows oversold bounce potential with B+ grade from Meyka AI.
VR.CN Stock Surges 900% on CNQ Exchange, Victory Resources Gains Momentum
VR.CN stock jumps 900% to C$0.10 on CNQ. Victory Resources explores lithium, gold, and precious metals across North America.
MGLG Stock Surges on 141 Million Share Volume Spike Apr 27
MGLG stock trades on massive 10.7M volume spike with penny stock volatility. Magellan Energy analysis on PNK exchange.
Princess Kako April 28: Royal Compassion Reshapes Japan’s Diplomacy
Princess Kako visits Hamamatsu to support Japanese-Brazilian communities and strengthen Japan’s diplomatic ties with diaspora populations.
4564.T Stock Falls 4% on April 27 as OncoTherapy Science Faces Headwinds
4564.T stock dropped 4% to ¥24.0 on April 27, 2026. OncoTherapy Science faces strong sell rating amid biotech pipeline challenges.
0910.HK Stock Bounces 12.5% Lower on April 27 as China Sandi Holdings Faces Headwinds
0910.HK stock drops 12.5% to HK$0.014 on HKSE. China Sandi Holdings faces real estate challenges with negative earnings and weak fundamentals.
Ajax Therapeutics to Be Acquired by Eli Lilly in Deal Worth Up to $2.3 Billion
The biotechnology sector in the global stock market received major attention after the announcement that Ajax Therapeutics will be acquired by Eli Lilly in a deal valued at up to $2.3 billion. The acquisition highlights the growing importance of precision medicine and targeted therapies in the pharmaceutical industry. This move is being closely watched by…